BCYC
Price
$3.62
Change
-$0.04 (-1.09%)
Updated
Nov 2 closing price
Capitalization
253.37M
119 days until earnings call
Intraday BUY SELL Signals
SRRK
Price
$42.91
Change
-$0.99 (-2.26%)
Updated
Nov 2 closing price
Capitalization
5.23B
7 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCYC vs SRRK

BCYC vs SRRK Comparison Chart in %
View a ticker or compare two or three
VS
BCYC vs. SRRK commentary
Nov 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Buy and SRRK is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BCYC with price predictions
Nov 02, 2026

Aroon Indicator for BCYC shows an upward move is likely

BCYC's Aroon Indicator triggered a bullish signal on November 02, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 137 similar instances where the Aroon Indicator showed a similar pattern. In 120 of the 137 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BCYC's RSI Indicator exited the oversold zone, 37 of 48 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on BCYC as a result. In 62 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.

The Moving Average Convergence Divergence (MACD) for BCYC just turned positive on October 22, 2026. Looking at past instances where BCYC's MACD turned positive, the stock continued to rise in 35 of 46 cases over the following month. The odds of a continued upward trend are 76%.

Following a +6.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where BCYC advanced for three days, in 188 of 247 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 48 cases where BCYC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

BCYC moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BCYC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

BCYC broke above its upper Bollinger Band on October 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 28 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.497) is normal, around the industry mean (3.104). P/E Ratio (-1.326) is within average values for comparable stocks, (-0.958). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (129.907) among similar stocks. P/S Ratio (4.136) is also within normal values, averaging (439.647).

The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. BCYC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BCYC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for SRRK with price predictions
Nov 02, 2026

SRRK's RSI Oscillator ascends from oversold territory

The RSI Indicator for SRRK moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In 23 of the 28 cases the stock moved higher. This puts the odds of a move higher at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on SRRK as a result. In 72 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

The Moving Average Convergence Divergence (MACD) for SRRK just turned positive on October 21, 2026. Looking at past instances where SRRK's MACD turned positive, the stock continued to rise in 39 of 49 cases over the following month. The odds of a continued upward trend are 80%.

Following a +3.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRRK advanced for three days, in 231 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRRK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

SRRK broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SRRK entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. SRRK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRRK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.592) is normal, around the industry mean (3.104). P/E Ratio (-12.964) is within average values for comparable stocks, (-0.958). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (129.907) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.647).

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
BCYC vs SRRK: Fundamental Ratings
BCYC
SRRK
OUTLOOK RATING
1..100
1418
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
79
Overvalued
PROFIT vs RISK RATING
1..100
10070
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
7356
P/E GROWTH RATING
1..100
2826
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCYC's Valuation (35) in the null industry is somewhat better than the same rating for SRRK (79) in the Biotechnology industry. This means that BCYC’s stock grew somewhat faster than SRRK’s over the last 12 months.

SRRK's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as BCYC (100) in the null industry. This means that SRRK’s stock grew similarly to BCYC’s over the last 12 months.

BCYC's SMR Rating (97) in the null industry is in the same range as SRRK (99) in the Biotechnology industry. This means that BCYC’s stock grew similarly to SRRK’s over the last 12 months.

SRRK's Price Growth Rating (56) in the Biotechnology industry is in the same range as BCYC (73) in the null industry. This means that SRRK’s stock grew similarly to BCYC’s over the last 12 months.

SRRK's P/E Growth Rating (26) in the Biotechnology industry is in the same range as BCYC (28) in the null industry. This means that SRRK’s stock grew similarly to BCYC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCYCSRRK
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 03, 2026
Stock price -- (BCYC: $3.62 vs. SRRK: $42.91)
Brand notoriety: BCYC and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 67% vs. SRRK: 45%
Market capitalization -- BCYC: $253.37M vs. SRRK: $5.23B
BCYC [@Biotechnology] is valued at $253.37M. SRRK’s [@Biotechnology] market capitalization is $5.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $140.2B. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green while SRRK’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • SRRK’s FA Score: 1 green, 4 red.
According to our system of comparison, BCYC is a better buy in the long-term than SRRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish while SRRK’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 5 bullish, 4 bearish.
  • SRRK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than SRRK.

Price Growth

BCYC (@Biotechnology) experienced а -0.82% price change this week, while SRRK (@Biotechnology) price change was +2.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.92%. For the same industry, the average monthly price growth was -13.16%, and the average quarterly price growth was -20.21%.

Reported Earning Dates

BCYC is expected to report earnings on Mar 02, 2027.

SRRK is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-0.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BCYC
Daily Signal:
Gain/Loss:
SRRK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PCVX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-1.09%
PCVX - BCYC
57%
Loosely correlated
-2.27%
ARCT - BCYC
50%
Loosely correlated
-13.96%
EDIT - BCYC
49%
Loosely correlated
-3.75%
RCKT - BCYC
49%
Loosely correlated
+1.23%
STOK - BCYC
48%
Loosely correlated
+0.72%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with RYTM. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then RYTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
-2.26%
RYTM - SRRK
51%
Loosely correlated
+0.94%
PTGX - SRRK
45%
Loosely correlated
-3.78%
ARVN - SRRK
44%
Loosely correlated
-4.33%
CGON - SRRK
42%
Loosely correlated
-4.21%
VERA - SRRK
42%
Loosely correlated
-2.36%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WEBS18.450.63
+3.54%
Direxion Daily Dow Jones Internet Bear 3X ETF (WEBS)
MBOX42.800.11
+0.25%
Freedom Day Dividend ETF (MBOX)
BBHL17.500.03
+0.18%
BBH Select Large Cap ETF (BBHL)
DEM52.71-0.09
-0.17%
WisdomTree Emerging Markets High Dividend Fund (DEM)
CPNJ27.45-0.10
-0.37%
Calamos 100 Structured Alt Protection ETF (CPNJ)